![]() |
|
|
Vol. 290, Issue 1, 66-75, July 1999
Department of Biomedical Science, McMaster University, Hamilton,
Ontario, Canada (J.-A.E.T.F.-T., Z.W., K.I., E.E.D.); and Department of
Medicine and Robarts Research Institute, University of Western Ontario,
London, Ontario, Canada (T.J.M.)
Pituitary adenylate cyclase-activating peptide
(PACAP)1-27, PACAP1-38, and vasoactive
intestinal peptide (VIP) initiated dose-dependent contractions of
canine ileal circular muscle after intra-arterial injection in vivo or
ex vivo. PACAP1-27- and VIP-induced contractions
approached the tissue maximum; VIP was 100-fold less potent.
PACAP1-38 was more potent than VIP. PACAP1-27
contractions in vivo were unaffected by hexamethonium, reduced equally
by atropine or atropine plus hexamethonium, and abolished by
tetrodotoxin (TTX), suggesting that PACAP released acetylcholine and
another excitatory neurotransmitter from postganglionic cholinergic
enteric nerves. In myenteric plexus-free circular muscle
strips, PACAP1-27 at 10
9 M
and PACAP1-38 or VIP at 10
7 M increased
[3H]acetylcholine release during nerve stimulation,
suggesting the locus of one postganglionic site at which
PACAP1-27 acts. All agonists inhibited nerve-mediated
contractions in vivo with a potency rank order similar to that for
excitation. Inhibition of nitric oxide (NO) synthetase or TTX decreased
the duration and amplitude of PACAP1-27- but not
PACAP1-38-induced inhibition. Inhibition of NO synthetase
abolished VIP-induced inhibition, but TTX did not. Submaximal
contractions to acetylcholine were amplified by PACAP1-27
or VIP before TTX and inhibited after TTX. Thus, both PACAP molecules
and VIP directly inhibit and indirectly excite smooth muscle
contractions. PACAP1-27 and VIP also release NO. The
functional potency differences between PACAP1-27 and VIP
suggest PAC1 receptors mediate all responses, likely
through the stimulation of adenylate cyclase.
This article has been cited by other articles:
![]() |
K. M. Braas, V. May, P. Zvara, B. Nausch, J. Kliment, J. D. Dunleavy, M. T. Nelson, and M. A. Vizzard Role for pituitary adenylate cyclase activating polypeptide in cystitis-induced plasticity of micturition reflexes Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R951 - R962. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Daniel, M. Anvari, J. E. T. Fox-Threlkeld, and T. J. McDonald Local, exendin-(939)-insensitive, site of action of GLP-1 in canine ileum Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G595 - G602. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Daniel, T. J. Bowes, and J. Jury Roles of Guanylate Cyclase in Responses to Myogenic and Neural Nitric Oxide in Canine Lower Esophageal Sphincter J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1111 - 1118. [Abstract] [Full Text] [PDF] |
||||